Pfizer, sell signal under management for 10 weeks
Pfizer dips 0.6% as money flow keeps climbing back toward zero
Pfizer, sell signal under management for 10 weeks
Our view last week
Ninth week of the sell signal on Pfizer, and the week closed nearly flat (+0.1%) after two straight down weeks. Buying volume climbed back to 70%, and a double bottom formed in the 24 area on the daily chart with an intermediate 6% rebound. The short-term technical picture, though, hasn't turned yet: MACD and the histogram remain worse than a month ago.
This week's summary
Pfizer shares form a double bottom in the 24 area for the second week running, with buying volume steady at 70% despite a 0.6% dip. Money flow, which bottomed two weeks ago, has climbed steadily back to a hair's breadth from zero: selling pressure is fading. The Sell signal, now in its 10th week of management, remains in profit for the short.
IQS Phase
84
in tension / maturity
Signal Strength
18
decline starting to make lower lows
Sizing
MINIMUM
Ranking
#62 / 137
US stocks
Trade P&L %
+5.88%
from signal to today
restricted Platinum content